tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GLUE Stock Latest News

Monte Rosa Therapeutics files automatic mixed securities shelf
The FlyMonte Rosa Therapeutics files automatic mixed securities shelf
7d ago
GLUE
Monte Rosa Therapeutics price target raised to $37 from $27.50 at Piper Sandler
PremiumThe Fly
Monte Rosa Therapeutics price target raised to $37 from $27.50 at Piper Sandler
1M ago
GLUE
Monte Rosa Therapeutics Prices $300 Million Public Offering
PremiumCompany Announcements
Monte Rosa Therapeutics Prices $300 Million Public Offering
1M ago
8K
GLUE
Monte Rosa Therapeutics 11.125M share Secondary priced at $24.00
PremiumThe Fly
Monte Rosa Therapeutics 11.125M share Secondary priced at $24.00
1M ago
GLUE
Monte Rosa Therapeutics Ends Current ATM Equity Program
PremiumCompany Announcements
Monte Rosa Therapeutics Ends Current ATM Equity Program
1M ago
8K
GLUE
Monte Rosa Therapeutics announces $200M common stock offering
PremiumThe FlyMonte Rosa Therapeutics announces $200M common stock offering
1M ago
GLUE
Monte Rosa Therapeutics price target raised to $31 from $22 at Jefferies
Premium
The Fly
Monte Rosa Therapeutics price target raised to $31 from $22 at Jefferies
1M ago
GLUE
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
1M ago
AAL
AMD
Midday Fly By: Warner Bros. urges holders to reject Paramount bid
PremiumThe Fly
Midday Fly By: Warner Bros. urges holders to reject Paramount bid
1M ago
W
BA
Monte Rosa data position MRT-8102 ‘favorably,’ says LifeSci Capital
PremiumThe Fly
Monte Rosa data position MRT-8102 ‘favorably,’ says LifeSci Capital
1M ago
GLUE
Monte Rosa Therapeutics price target raised to $37 from $26 at Wedbush
PremiumThe Fly
Monte Rosa Therapeutics price target raised to $37 from $26 at Wedbush
1M ago
GLUE
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
PremiumMarket News
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
1M ago
GLUE
Monte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
PremiumRatingsMonte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
1M ago
GLUE
Monte Rosa reports positive Phase 1 data for MRT-8102
Premium
Company Announcements
Monte Rosa reports positive Phase 1 data for MRT-8102
1M ago
8K
GLUE
Monte Rosa Therapeutics announces Phase 1 data of MRT-8102
Premium
The Fly
Monte Rosa Therapeutics announces Phase 1 data of MRT-8102
1M ago
GLUE
Monte Rosa Therapeutics: Promising Progress with MRT-2359 in Advanced Prostate Cancer
PremiumRatings
Monte Rosa Therapeutics: Promising Progress with MRT-2359 in Advanced Prostate Cancer
2M ago
GLUE
Monte Rosa Reports Positive Phase 1/2 Study Results
PremiumCompany Announcements
Monte Rosa Reports Positive Phase 1/2 Study Results
2M ago
8K
GLUE
Monte Rosa Therapeutics announces data from Phase 1/2 study of MRT-2359
PremiumThe Fly
Monte Rosa Therapeutics announces data from Phase 1/2 study of MRT-2359
2M ago
GLUE
Wells upgrades Monte Rosa to Overweight on 2026 catalysts
PremiumThe Fly
Wells upgrades Monte Rosa to Overweight on 2026 catalysts
2M ago
GLUE
Monte Rosa Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe FlyMonte Rosa Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
2M ago
GLUE
Monte Rosa Therapeutics presents preclinical data on MRT-8102
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data on MRT-8102
3M ago
GLUE
Monte Rosa Therapeutics Reports Strong Revenue Growth
Premium
Company Announcements
Monte Rosa Therapeutics Reports Strong Revenue Growth
3M ago
GLUE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >